Fisher & Paykel Healthcare Corporation Limited (FSPKF)
USD 17.48
(8.23%)
USD 17.48
(8.23%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 353.4 Million NZD | -23.99% |
| 2023 | 334.7 Million NZD | -34.26% |
| 2022 | 509.1 Million NZD | -29.6% |
| 2021 | 723.2 Million NZD | 93.16% |
| 2020 | 374.4 Million NZD | 10.9% |
| 2019 | 337.6 Million AUD | 6.8% |
| 2018 | 316.1 Million AUD | 12.48% |
| 2017 | 281.02 Million AUD | 14.06% |
| 2016 | 246.38 Million AUD | 22.05% |
| 2015 | 201.87 Million AUD | 15.8% |
| 2014 | 174.33 Million AUD | 23.91% |
| 2013 | 140.69 Million AUD | 21.67% |
| 2012 | 115.63 Million AUD | -3.95% |
| 2011 | 120.39 Million AUD | -0.46% |
| 2010 | 120.94 Million AUD | -0.01% |
| 2009 | 120.95 Million AUD | 61.07% |
| 2008 | 75.09 Million AUD | -27.57% |
| 2007 | 103.68 Million AUD | -1.46% |
| 2006 | 105.21 Million AUD | 4.44% |
| 2005 | 100.74 Million AUD | 12.24% |
| 2004 | 89.76 Million AUD | -25.27% |
| 2003 | 120.11 Million AUD | 25.31% |
| 2002 | 95.85 Million AUD | 403.97% |
| 2001 | 19.01 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 100.4 Million NZD | 0.0% |
| 2024 Q2 | 164.7 Million NZD | 115.86% |
| 2024 Q3 | 100.4 Million NZD | -39.04% |
| 2024 FY | 368.7 Million NZD | 10.16% |
| 2024 Q1 | 76.3 Million NZD | -63.51% |
| 2023 Q1 | 63.35 Million NZD | -65.63% |
| 2023 Q2 | 130.6 Million NZD | 106.16% |
| 2023 Q4 | 209.1 Million NZD | 103.5% |
| 2023 FY | 334.7 Million NZD | -34.26% |
| 2023 Q3 | 102.75 Million NZD | -21.32% |
| 2022 Q4 | 184.3 Million NZD | 81.4% |
| 2022 Q1 | 151.2 Million NZD | -60.18% |
| 2022 FY | 509.1 Million NZD | -29.6% |
| 2022 Q2 | 282 Million NZD | 86.51% |
| 2022 Q3 | 101.6 Million NZD | -63.97% |
| 2021 Q1 | 154.6 Million NZD | -29.6% |
| 2021 Q3 | 201.55 Million NZD | -34.9% |
| 2021 Q4 | 379.7 Million NZD | 88.39% |
| 2021 FY | 723.2 Million NZD | 93.16% |
| 2021 Q2 | 309.6 Million NZD | 100.26% |
| 2020 Q1 | 83 Million NZD | -1.95% |
| 2020 Q4 | 219.6 Million NZD | 105.91% |
| 2020 Q3 | 106.65 Million NZD | -37.04% |
| 2020 FY | 374.4 Million NZD | 10.9% |
| 2020 Q2 | 169.4 Million NZD | 104.1% |
| 2019 FY | 337.6 Million AUD | 6.8% |
| 2019 Q4 | 84.65 Million NZD | 0.0% |
| 2019 Q3 | 84.65 Million NZD | 15.41% |
| 2019 Q2 | 73.35 Million NZD | 0.0% |
| 2019 Q1 | 73.35 Million NZD | -5.23% |
| 2018 Q3 | 77.4 Million NZD | 34.61% |
| 2018 FY | 316.1 Million AUD | 12.48% |
| 2018 Q1 | 57.5 Million NZD | -11.13% |
| 2018 Q2 | 57.5 Million NZD | 0.0% |
| 2018 Q4 | 77.4 Million NZD | 0.0% |
| 2017 Q1 | 55.35 Million NZD | -4.47% |
| 2017 FY | 281.02 Million AUD | 14.06% |
| 2017 Q4 | 64.7 Million NZD | 0.0% |
| 2017 Q3 | 64.7 Million NZD | 16.89% |
| 2017 Q2 | 55.35 Million NZD | 0.0% |
| 2016 Q4 | 57.93 Million NZD | 0.0% |
| 2016 Q3 | 57.93 Million NZD | 21.72% |
| 2016 Q2 | 47.6 Million NZD | 0.0% |
| 2016 Q1 | 47.6 Million NZD | -2.32% |
| 2016 FY | 246.38 Million AUD | 22.05% |
| 2015 Q1 | 36.31 Million NZD | -5.14% |
| 2015 Q3 | 48.73 Million NZD | 34.2% |
| 2015 Q4 | 48.73 Million NZD | 0.0% |
| 2015 FY | 201.87 Million AUD | 15.8% |
| 2015 Q2 | 36.31 Million NZD | 0.0% |
| 2014 Q1 | 33.46 Million NZD | 3.17% |
| 2014 FY | 174.33 Million AUD | 23.91% |
| 2014 Q3 | 38.28 Million NZD | 14.37% |
| 2014 Q2 | 33.46 Million NZD | 0.0% |
| 2014 Q4 | 38.28 Million NZD | 0.0% |
| 2013 Q4 | 32.44 Million NZD | 0.0% |
| 2013 Q3 | 32.44 Million NZD | 0.0% |
| 2013 FY | 140.69 Million AUD | 21.67% |
| 2012 FY | 115.63 Million AUD | -3.95% |
| 2011 FY | 120.39 Million AUD | -0.46% |
| 2010 FY | 120.94 Million AUD | -0.01% |
| 2009 FY | 120.95 Million AUD | 61.07% |
| 2008 FY | 75.09 Million AUD | -27.57% |
| 2007 FY | 103.68 Million AUD | -1.46% |
| 2006 FY | 105.21 Million AUD | 4.44% |
| 2005 FY | 100.74 Million AUD | 12.24% |
| 2004 FY | 89.76 Million AUD | -25.27% |
| 2003 FY | 120.11 Million AUD | 25.31% |
| 2002 FY | 95.85 Million AUD | 403.97% |
| 2001 FY | 19.01 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -30255.088% |
| Ansell Limited | 129.3 Million USD | -173.318% |
| Ansell Limited | 129.3 Million USD | -173.318% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -1034.941% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 22247.006% |
| Psykey, Inc. | -797.5 Thousand USD | 44413.257% |
| ConvaTec Group Plc | 262.7 Million USD | -34.526% |
| ConvaTec Group Plc | 262.7 Million USD | -34.526% |
| Encision Inc. | -640.78 Thousand USD | 55251.276% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 249306.685% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 321577.304% |
| Innovative MedTech Inc. | -4.27 Million USD | 8368.454% |
| LifePoint, Inc. | -7.49 Million USD | 4815.0% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 5553.704% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -106990.909% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 287674.253% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 75729.497% |
| SmileDirectClub, Inc. | -241.15 Million USD | 246.544% |
| Sector 10, Inc. | -39.84 Thousand USD | 887059.141% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -10.573% |
| SheerVision, Inc. | 155.72 Thousand USD | -226837.056% |
| United Health Products, Inc. | -2.42 Million USD | 14663.953% |
| Vasamed, Inc. | 4.74 Million USD | -7352.077% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 15504.459% |
| Yubo International Biotech Limited | -1.2 Million USD | 29422.374% |